Skip to main content

Day: March 20, 2026

Gauzy Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

No Impact to Ongoing Operations or Trading; Company Evaluating All Options to Address Requirement Within Compliance Period TEL AVIV, Israel, March 20, 2026 (GLOBE NEWSWIRE) — Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a global leader in vision and light control technologies, today announced that on March 17, 2026 it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5450(a)(1). The notification was issued because the closing bid price of the Company’s ordinary shares was below $1.00 per share for 30 consecutive business days, which is the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1). The notice has...

Continue reading

Daré Bioscience to Host Full Year 2025 Financial Results and Company Update Conference Call and Webcast on March 26, 2026

SAN DIEGO, March 20, 2026 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, March 26, 2026, to review its financial results for the year ended December 31, 2025 and to provide a company update. To access the conference call via phone, dial (646) 307-1963 or (800) 715-9871 (toll-free). The conference ID number for the call is 1717423. The live webcast can be accessed under “Presentations, Events & Webcasts” in the Investors section of the company’s website at http://ir.darebioscience.com. Please log in approximately 5-10 minutes prior to the call to register and to download and install...

Continue reading

VenHub Advances Autonomous Smart Store Security to Tackle Rising Retail Industry Theft and Shrink

LAS VEGAS, March 20, 2026 (GLOBE NEWSWIRE) — VenHub Global, Inc. (NASDAQ: VHUB) (“VenHub” or the “Company”), a leader in fully autonomous Smart Store technology, today highlighted its expansive portfolio of new retail security-focused technologies that are helping to address the many billions of dollars in losses impacting the industry. The six new innovations highlighted are solutions that advance the Company’s Smart Store functionality across the “Advanced Security & Protection Systems” category. “We are focused on technology innovations for our Smart Stores that address the challenges of traditional retail to empower consumers with an easy and enjoyable shopping experience while also providing quantifiable financial benefits for our Smart Store operators,” said Shahan Ohanessian, CEO at VenHub. “Theft and product shrinkage...

Continue reading

New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease

Findings underpin potential of Anavex’ lead candidate blarcamesine through its upstream mechanism of action and SIGMAR1-mediated autophagy restoration NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that a new peer-reviewed study published by University of California in Proceedings of the National Academy of Sciences, Nexus1 (Shoff et al., 2026) supports the hypothesis that disruption of neuronal homeostasis—particularly autophagy impairment—acts upstream of amyloid...

Continue reading

DEEP SEA MINERALS CORP. SUBMITS RESPONSE TO U.S. DEFENSE INDUSTRIAL BASE CONSORTIUM SOLICITATION FOR CRITICAL MINERALS

Vancouver, BC, March 20, 2026 (GLOBE NEWSWIRE) — Deep Sea Minerals Corp. (CSE: SEAS) (OTCQB: DSEAF) (FSE: X45) (“Deep Sea Minerals” or the “Company”), a subsea mineral exploration and development company focused on advancing critical mineral opportunities from the deep ocean, is pleased to announce that it has submitted its bid in response to a solicitation from the U.S. Defense Industrial Base Consortium (the “DIBC”) to provide to the United States a reliable supply of critical minerals, focusing on Nickel (Ni), and a complementary commercialization plant. In February 2026, the DIBC issued a new request for project proposal (“RPP”) focused on strategic critical minerals. The DoW has prioritized identification of supply chain alternatives for defense-critical minerals used in the production of aircraft, missiles,...

Continue reading

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST™ (etripamil) Nasal Spray for the Treatment of PSVT

FDA approval of CARDAMYST represents first new option in 30 years for the more than two million patients with PSVT Participants using CARDAMYST in clinical studies were 2x more likely to convert symptomatic PSVT to sinus rhythm and did so more than 3x faster compared with placebo CARDAMYST launch execution on track with positive initial engagement in the product from healthcare providers and payers $200 million pro forma cash supports strong launch and operating runway into late 2027; includes $106 million of cash at year-end and net proceeds from subsequent financing activities1 Company to host investor call and webcast at 8:30am ET todayMONTREAL and CHARLOTTE, N.C., March 20, 2026 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization...

Continue reading

Baker Hughes Announces Dates for First-quarter Earnings Release and Webcast 

HOUSTON and LONDON, March 20, 2026 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR) will announce the results of the first quarter ending March 31, 2026, via press release at 5 p.m. Eastern Time (4 p.m. Central Time) on Thursday, April 23, 2026. A webcast to discuss the results will be held Friday, April 24, at 9:30 a.m. Eastern Time (8:30 a.m. Central Time). To access the webcast, listeners should visit the Baker Hughes website at: investors.bakerhughes.com. An archived version will be available on the website following the webcast. About Baker HughesBaker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide. Built on a century of experience and conducting business in over 120 countries, our innovative technologies and services are taking energy forward – making...

Continue reading

OMS Energy Technologies (NASDAQ: OMSE) Saudi Arabia Subsidiary Receives US$11 Million Call-Off Order from Saudi Aramco Under Long-Term Supply Agreement

Specialty Connector Order Under 10-Year Agreement Reinforces OMS Saudi’s Position as a Premier Regional Supplier Singapore, March 20, 2026 (GLOBE NEWSWIRE) — OMS Energy Technologies Inc. (“OMS” or the “Company”) (NASDAQ: OMSE), a growth-oriented manufacturer of surface wellhead systems (“SWS”) and oil country tubular goods (“OCTG”) for the oil and gas industry, today announced that its wholly-owned subsidiary, OMS Oilfield Services Arabia Ltd. (“OMS Saudi”), has received a US$11 million call-off order for specialty connectors and pipes under the Company’s existing long-term supply agreement with Saudi Aramco, the world’s largest oil producer. The products are expected to be delivered during calendar year 2026. The Company’s supply agreement with Saudi Aramco, signed in early 2024, operates on a call-off...

Continue reading

Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer

Thomas A. Zalewski, a Partner at Day Pitney LLP, appointed Chief Legal Officer and Chief Compliance Officer effective April 2, 2026 Lori J. Braender to remain in a non-executive role as Corporate Secretary after nearly eight years as Chief Legal Officer, Chief Compliance Officer and Corporate SecretaryWARREN, N.J., March 20, 2026 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today announced the appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer, effective April 2, 2026, succeeding Lori J. Braender, who will be stepping down as Chief Legal Officer and Chief Compliance...

Continue reading

WeShop Announces $2.0 Million Proceeds from the Exercise of Performance Incentive Grants 

212,156 Performance Incentive Grants were exercised at $9.64 per share between January 30, 2026, and March 17, 2026, generating $2,045,184 in proceeds for WeShop Proceeds will support working capital and general corporate purposes as WeShop continues expansion across North AmericaLONDON, March 20, 2026 (GLOBE NEWSWIRE) — WeShop Holdings Limited (“WeShop” or the “Company”) (NASDAQ: WSHP), the world’s first community-owned social commerce platform, today announced that holders of the WeShop Performance Incentive Grants have exercised their grants to purchase the Company’s Class A ordinary shares.  Since the listing on 14th November 2025, the holders of Performance Incentive Grants have exercised a total of 212,156 grants at $9.64 per share.  These exercises generated aggregate proceeds to the Company of $2,045,184. The proceeds...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.